2 Less than 1% of patients in an efficacy and safety trial reported a skin adverse event
Eli Lillys triple hormone receptor agonist cut body weight by 26.6% on a placebo-adjusted basis and reduced knee osteoarthritis pain by 75%, capping off a trio of wildly successful readouts for the pharmas obesity pipeline
Currently, five states offer unrestricted Medicaid coverage for Wegovy, and four states offer restricted coverage with prior authorization
It's worth reading further before you decide - the details on how compounding status, approval gatekeeping, and refund terms actually work in practice matter a lot for this category
Your doctor can help determine which option balances effectiveness, safety, and affordability for your situation
Rev Recent Clin Trials 2015;10:6877